Cellectis · 3 days ago
Scientist II, Immuno-Oncology
New York, United States
Full-time
Onsite
Mid Level
3+ years expCellectis is a company focused on creating cutting-edge cellular treatments for cancer and other serious diseases. They are seeking a Scientist II in Immuno-Oncology to develop innovative adoptive cell therapies, design and analyze experiments, and communicate scientific data effectively within a collaborative team environment.
BiopharmaBiotechnologyHealth CareMedicalOncology
No H1B
Responsibilities
Develop innovative adoptive cell therapies to treat cancer or other serious diseases
Design, execute, and analyze in vitro experiments (some examples include engineering of CAR T-cells, cytotox, ELISA, proliferation assays, flow cytometry analysis, cell culture)
Design, execute and analyze in vivo preclinical studies (some examples of procedures include tumor implantation, adoptive cell therapy administration, mice dosing through different administration routes, tumor monitoring, blood collection and multiple tissue analysis)
Efficiently and clearly present and communicate scientific data to the team, cross-functionally and at external meetings
Pro-actively suggest and evaluate innovative cell engineering solutions and develop new assays to enhance the company’s intellectual portfolio and contribute to peer-reviewed publications
Stay up to date with external scientific research from academic and industry institutions
Keep timely detailed documentation of experiments
Effectively plan and manage projects and deliverables to meet deadlines
Foster cross-functional collaborations and train other colleagues
Prioritize company objectives and work towards shared success
Other duties as necessary to ensure the daily operations of the lab and support the team
Qualification
Required
PhD in oncology, immunology, or equivalent (minimum of 3 years of experience after PhD in related role)
Experience in human T-cell biology, immuno-oncology and knowledge in cell engineering technologies
Hands on experience and troubleshooting proficiency in immunology assays including immune cell isolation, multicolor flow cytometry, immune cell and cytokine profiling assays using conventional and next-generation analytical methods
Demonstrated experience designing and executing mouse tumor model experiments including mouse handling (injections- IV, SC, IP- and organ dissection)
Excellent abilities to analyze and synthesize data for different audiences and report types while supporting decision-making processes
Proficiency in molecular biology as well as analyzing and manipulating DNA/protein sequences using bioinformatics software is desired
Basic knowledge of gene editing and next-generation sequencing technologies is a plus
Experience in working in matrixed environments and in project management is desired
Strong record of scientific publications and demonstrated scientific curiosity
Willingness to quickly adapt, innovate, discover new approaches, collaborate and support the team towards shared company goals
Candidates should be authorized to work in the U.S., preferably without the need for current, or future, sponsorship
Role is onsite and based in New York, NY
Preferred
Proficiency in molecular biology as well as analyzing and manipulating DNA/protein sequences using bioinformatics software is desired
Experience in working in matrixed environments and in project management is desired
Company
Cellectis
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$393.48MKey Investors
European Investment BankAstraZeneca
2024-12-10Post Ipo Debt· $5.27M
2023-11-01Post Ipo Equity· $140M
2023-02-07Post Ipo Equity· $24.35M
Leadership Team
A
Arthur Stril
Chief Financial Officer & Chief Business Officer
Recent News
2026-01-06
2025-12-16
Company data provided by crunchbase